Le Lézard
Classified in: Health, Business
Subjects: CSR, SRI

MCAN Health Announces Sponsorship to UK National Pharmacy Association, in line with UK Prime Minister Rishi Sunak's Vision for Local Pharmacies


ISTANBUL, Feb. 9, 2024 /PRNewswire/ -- MCAN Health, an internationally accredited medical travel company based in Istanbul is pleased to declare its sponsorship of the UK's National Pharmacy Association.

Gulsultan Dogan, the visionary founder of MCAN Health, is pleased to announce the company's sponsorship of the National Pharmacy Association (NPA), a notable and non-profit organization focused on enhancing community health services across the United Kingdom. Upon the invitation letter, Dogan states, ''We did not hesitate to show our support and positively answer the invitation letter. As a professional in the healthcare sector for years, I firmly believe medical care is a human right that should be accessible to everyone without enduring lengthy waiting lists. NPA's mission to boost community health services in United Kingdom aligns perfectly with our core values which is the dedication to improving global healthcare accessibility.''

Esteemed UK Prime Minister Rishi Sunak, who worked in his mother's pharmacy during his youth, also shows his support to the NPA and recognizes the indispensable role of local pharmacies. Sunak, having personally witnessed the invaluable contributions of these pharmacies to the health of the UK community, emphasizes the need to empower individuals to access care services conveniently at local pharmacies, thereby reducing the strain on GP waiting lists.

Aligned with Sunak's vision, MCAN Health acknowledges and values the power and contribution of local pharmacies in raising healthcare standards within the UK community.

About MCAN Health

Established in 2015, MCAN Health has been offering services in hair transplants, dental treatments, and plastic surgery for international patients in Istanbul, Turkey. Employing a forward-thinking and technology-driven approach, the company is recognized for its innovative contributions to the sector.

Through various initiatives, including obtaining international TEMOS accreditation, achieving an NPS score of 8.8, and garnering positive reviews on independent platforms, the company aims to demonstrate its commitment to quality and patient satisfaction. It also has received several awards over the years, with the latest one 'The Most Successful Health Tourism of the Year' at the Social Responsibility Awards, presented by the Health Volunteers Turkey Association. This accolade was granted to MCAN Health by the respected juries in the healthcare sector for being the most socially and environmentally responsible company in the sector. MCAN Health's core values, as highlighted by CEO Dogan, include patient and quality-centric care, staying current with technological advancements, environmental and social responsibility, and a strong emphasis on diversity and inclusion. These principles are the foundation of the company's culture.

Related Links: https://www.mcanhealth.com/ 

Media Contact:
Özümsu Alagöz
0553 6273765
[email protected] 

Photo : https://mma.prnewswire.com/media/2337862/MCAN.jpg

 


These press releases may also interest you

8 mai 2024
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

8 mai 2024
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

8 mai 2024
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

8 mai 2024
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

8 mai 2024
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...



News published on and distributed by: